{ "items" : [
    { "id" : "http://webisa.webdatacommons.org/105684706"
      "properties" : {
        "http://www.w3.org/1999/02/22-rdf-syntax-ns#type" : [ "http://www.w3.org/ns/prov#Entity" ] ,
        "http://www.w3.org/ns/prov#value" : [ "Some physicians and patients have expressed concern that bioequivalent generic and brand-name drugs may not be equivalent in their effects on various clinical parameters, including physiological measures such as heart rate or blood pressure, important laboratory measurements, and outcomes such as health system utilization or mortality.8- 10 Of particular concern are narrow therapeutic index (NTI)" ] ,
        "http://www.w3.org/ns/prov#wasQuotedFrom" : [ "jamanetwork.com" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/347583544"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/105684706" ] } },

    { "id" : "http://webisa.webdatacommons.org/prov/4238716"
      "properties" : {
        "http://www.w3.org/ns/prov#wasDerivedFrom" : [ "http://webisa.webdatacommons.org/105684706"] } } }
